Substrate-mediated reprogramming of human fibroblasts into neural crest stem-like cells and their applications in neural repair

Biomaterials

Volumn 102, Issue , 2016, Pages 148-161

  Tseng, Ting Chen ^a   Hsieh, Fu Yu ^a   Dai, Niann Tzyy ^b   Hsu, Shan hui ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Forkhead box D3 (FOXD3); Neural crest; Neural repair; Substrate mediated cell reprogramming

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; CELLS; CHITIN; CHITOSAN; CYTOLOGY; DISEASE CONTROL; DNA; FIBROBLASTS; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENES; REPAIR; STEM CELLS;

CELL REPROGRAMMING; EXPRESSION LEVELS; FORKHEAD BOX D3 (FOXD3); HUMAN FIBROBLAST; NEURAL CRESTS; NEURAL FUNCTIONS; NEURAL STEM CELL; NEUROLOGICAL DISEASE;

MOLECULAR BIOLOGY;

BETA TUBULIN; CD271 ANTIGEN; CHITOSAN; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXD3; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXD3 PROTEIN, HUMAN;

ADULT; ARTICLE; CELL PROLIFERATION; CELL RENEWAL; CELL VIABILITY; CONTROLLED STUDY; FEASIBILITY STUDY; FIBROBLAST; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MARKER GENE; NEURAL CREST CELL; NEURAL STEM CELL; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; SOMATIC CELL; UPREGULATION; ZEBRA FISH; ADMINISTRATION AND DOSAGE; ANIMAL; CELL CULTURE; CELL REPROGRAMMING TECHNIQUE; CHEMISTRY; CYTOLOGY; GENETICS; MALE; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; NEURAL CREST; PLASMID; PROCEDURES;

ADULT; ANIMALS; CELLS, CULTURED; CELLULAR REPROGRAMMING; CELLULAR REPROGRAMMING TECHNIQUES; CHITOSAN; FIBROBLASTS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MALE; NEURAL CREST; NEURAL STEM CELLS; NEUROGENESIS; PLASMIDS; TRANSFECTION; ZEBRAFISH;

EID: 84975795373     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.06.020     Document Type: Article

References (59)

1. [1] Yu, D.X., Marchetto, M.C., Gage, F.H., Therapeutic translation of iPSCs for treating neurological disease. Cell Stem Cell 12:6 (2013), 678–688.
2. [2] Stoessl, A.J., Gene therapy for Parkinson's disease: a step closer?. Lancet 383 (2014), 1107–1109.
3. [3] Picard-Riera, N., Nait-Oumesmar, B., Baron-Van Evercooren, A., Endogenous adult neural stem cells: limits and potential to repair the injured central nervous system. J. Neurosci. Res. 76:2 (2004), 223–231.
4. [4] Wichterle, H., Lieberam, I., Porter, J.A., Jessell, T.M., Directed differentiation of embryonic stem cells into motor neurons. Cell 110:3 (2002), 385–397.
5. [5] Lee, H., Shamy, G.A., Elkabetz, Y., Schofield, C.M., Harrsion, N.L., Panagiotakos, G., et al. Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells 25:8 (2007), 1931–1939.
6. [6] Prabhakaran, M.P., Venugopal, J.R., Ramakrishna, S., Mesenchymal stem cell differentiation to neuronal cells on electrospun nanofibrous substrates for nerve tissue engineering. Biomaterials 30:28 (2009), 4996–5003.
7. [7] Patel, M., Yang, S., Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Rev. 6:3 (2010), 367–380.
8. [8] Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., Yamanaka, S., Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:5903 (2008), 949–953.
9. [9] Huang, Y., Tan, S., Direct lineage conversion of astrocytes to induced neural stem cells or neurons. Neurosci. Bull. 31:3 (2015), 357–367.
10. [10] Takahashi, K., Okita, K., Nakagawa, M., Yamanaka, S., Induction of pluripotent stem cells from fibroblast cultures. Nat. Protoc. 2:12 (2007), 3081–3089.
11. [11] Hu, B.Y., Weick, J.P., Yu, J., Ma, L.X., Zhang, X.Q., Thomson, J.A., Zhang, S.C., Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl. Acad. Sci. U. S. A. 107:9 (2010), 4335–4340.
12. [12] Denham, M., Dottori, M., Neural differentiation of induced pluripotent stem cells. Methods Mol. Biol. 793 (2011), 99–110.
13. [13] Han, D.W., Tapia, N., Hermann, A., Hemmer, K., Höing, S., Araúzo-Bravo, M.J., et al. Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell 10:4 (2012), 465–472.
14. [14] Ring, K.L., Tong, L.M., Balestra, M.E., Javier, R., Andrews-Zwilling, Y., Li, G., et al. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell 11:1 (2012), 100–109.
15. [15] Redmer, T., Diecke, S., Grigoryan, T., Quiroga-Negreira, A., Birchmeier, W., Besser, D., E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming. EMBO Rep. 12:7 (2011), 720–726.
16. [16] Li, W., Tian, E., Chen, Z.X., Sun, G., Ye, P., Yang, S., et al. Identification of Oct4-activating compounds that enhance reprogramming efficiency. Proc. Natl. Acad. Sci. U. S. A. 109:51 (2012), 20853–20858.
17. [17] Yoo, J., Noh, M., Kim, H., Jeon, N.L., Kim, B.S., Kim, J., Nanogrooved substrate promotes direct lineage reprogramming of fibroblasts to functional induced dopaminergic neurons. Biomaterials 45 (2015), 36–45.
18. [18] Kulangara, K., Adler, A.F., Wang, H., Chellappan, M., Hammett, E., Yasuda, R., et al. The effect of substrate topography on direct reprogramming of fibroblasts to induced neurons. Biomaterials 35:20 (2014), 5327–5336.
19. [19] Choi, B., Park, K.S., Kim, J.H., Ko, K.W., Kim, J.S., Han, D.K., et al. Stiffness of hydrogels regulates cellular reprogramming efficiency through mesenchymal-to-epithelial transition and stemness markers. Macromol. Biosci., 2015, 10.1002/mabi.201500273.
20. [20] Liu, Y., Labosky, P.A., Regulation of embryonic stem cell self-renewal and pluripotency by Foxd3. Stem Cells 26:10 (2008), 2475–2484.
21. [21] Plank, J.L., Suflita, M.T., Galindo, C.L., Labosky, P.A., Transcriptional targets of Foxd3 in murine ES cells. Stem Cell Res. 12:1 (2014), 233–240.
22. [22] Zhu, L., Zhang, S., Jin, Y., Foxd3 suppresses NFAT-mediated differentiation to maintain the self-renewal of embryonic stem cells. EMBO Rep. 15:12 (2014), 1286–1296.
23. [23] Hsu, S.H., Huang, G.S., Ho, T.T., Feng, F., Efficient gene silencing in mesenchymal stem cells by substrate-mediated RNA interference. Tissue Eng. Part C Methods 20:11 (2014), 916–930.
24. [24] Pan, G., Li, J., Zhou, Y., Zheng, H., Pei, D., A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal. FASEB J. 20:10 (2006), 1730–1732.
25. [25] Lin, Y.H., Fu, K.Y., Hong, P.D., Ma, H., Liou, N.H., Ma, K.H., et al. The effects of microenvironment on wound healing by keratinocytes derived from mesenchymal stem cells. Ann. Plast. Surg. 71:Suppl. 1 (2013), S67–S74.
26. [26] Tseng, T.C., Hsu, S.H., Substrate-mediated nanoparticle/gene delivery to MSC spheroids and their applications in peripheral nerve regeneration. Biomaterials 35:9 (2014), 2630–2641.
27. [27] Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B., Schilling, T.F., Stages of embryonic development of the zebrafish. Dev. Dyn. 203:3 (1995), 253–310.
28. [28] Wu, C.C., Tsai, T.H., Chang, C., Lee, T.T., Lin, C., Cheng, I.H., Sun, M.C., et al. On the crucial cerebellar wound healing-related pathways and their cross-talks after traumatic brain injury in Danio rerio. PLoS One, 9(6), 2014, e97902.
29. [29] Tseng, T.C., Tao, L., Hsieh, F.Y., Wei, Y., Chiu, I.M., Hsu, S.H., An injectable, self-healing hydrogel to repair the central nervous system. Adv. Mater. 27:23 (2015), 3518–3524.
30. [30] Le Douarin, N.M., Creuzet, S., Couly, G., Dupin, E., Neural crest cell plasticity and its limits. Development 131:19 (2004), 4637–4650.
31. [31] Stewart, R.A., Arduini, B.L., Berghmans, S., George, R.E., Kanki, J.P., Henion, P.D., et al. Zebrafish foxd3 is selectively required for neural crest specification, migration and survival. Dev. Biol. 292:1 (2006), 174–188.
32. [32] Teng, L., Mundell, N.A., Frist, A.Y., Wang, Q., Labosky, P.A., Requirement for Foxd3 in maintenance of neural crest progenitors. Development 135:9 (2008), 1615–1624.
33. [33] Lister, J.A., Cooper, C., Nguyen, K., Modrell, M., Grant, K., Raible, D.W., Zebrafish Foxd3 is required for development of a subset of neural crest derivatives. Dev. Biol. 290:1 (2006), 92–104.
34. [34] Plank, J.L., Frist, A.Y., LeGrone, A.W., Magnuson, M.A., Labosk, P.A., Loss of Foxd3 results in decreased β-cell proliferation and glucose intolerance during pregnancy. Endocrinology 152:12 (2011), 4589–4600.
35. [35] Honoré, S.M., Aybar, M.J., Mayor, R., Sox10 is required for the early development of the prospective neural crest in Xenopus embryos. Dev. Biol. 260:1 (2003), 79–96.
36. [36] Cheung, M., Briscoe, J., Neural crest development is regulated by the transcription factor Sox9. Development 130:23 (2003), 5681–5693.
37. [37] McKeown, S.J., Lee, V.M., Bronner-Fraser, M., Newgreen, D.F., Farlie, P.G., Sox10 overexpression induces neural crest-like cells from all dorsoventral levels of the neural tube but inhibits differentiation. Dev. Dyn. 233:2 (2005), 430–444.
38. [38] Wang, Z., Oron, E., Nelson, B., Razis, S., Ivanova, N., Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. Cell Stem Cell 10:4 (2012), 440–454.
39. [39] Hanna, L.A., Foreman, R.K., Tarasenko, I.A., Kessler, D.S., Labosky, P.A., Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo. Genes Dev. 16:20 (2002), 2650–2661.
40. [40] Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113:5 (2003), 643–655.
41. [41] Hsu, S.H., Huang, G.S., Feng, F., Isolation of the multipotent MSC subpopulation from human gingival fibroblasts by culturing on chitosan membranes. Biomaterials 33 (2012), 2642–2655.
42. [42] Cassady, J.P., D'Alessio, A.C., Sarkar, S., Dani, V.S., Fan, Z.P., Ganz, K., et al. Direct lineage conversion of adult mouse liver cells and B lymphocytes to neural stem cells. Stem Cell Rep. 3:6 (2014), 948–956.
43. [43] Nitzan, E., Krispin, S., Pfaltzgraff, E.R., Klar, A., Labosky, P.A., Kalcheim, C., A dynamic code of dorsal neural tube genes regulates the segregation between neurogenic and melanogenic neural crest cells. Development 140:11 (2013), 2269–2279.
44. [44] Mundell, N.A., Plank, J.L., LeGrone, A.W., Frist, A.Y., Zhu, L., Shin, M.K., et al. Enteric nervous system specific deletion of Foxd3 disrupts glial cell differentiation and activates compensatory enteric progenitors. Dev. Biol. 363:2 (2012), 373–387.
45. [45] Zhang, Y., Tan, X., Sun, W., Xu, P., Zhang, P.J., Xu, Y., Characterization of flounder (Paralichthys olivaceus) FoxD3 and its function in regulating myogenic regulatory factors. In Vitro Cell Dev. Biol. Anim. 47:5–6 (2011), 399–405.
46. [46] Thomson, T.M., Rettig, W.J., Chesa, P.G., Green, S.H., Mena, A.C., Old, L.J., Expression of human nerve growth factor receptor on cells derived from all three germ layers. Exp. Cell Res. 174:2 (1988), 533–539.
47. [47] Stemple, D.L., Anderson, D.J., Isolation of a stem cell for neurons and glia from the mammalian neural crest. Cell 71:6 (1992), 973–985.
48. [48] Álvarez-Viejo, M., Menéndez-Menéndez, Y., Otero-Hernández, J., CD271 as a marker to identify mesenchymal stem cells from diverse sources before culture. World J. Stem Cells 7:2 (2015), 470–476.
49. [49] Kim, J., Lo, L., Dormand, E., Anderson, D.J., SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells. Neuron 38:1 (2003), 17–31.
50. [50] Mundell, N.A., Labosky, P.A., Neural crest stem cell multipotency requires Foxd3 to maintain neural potential and repress mesenchymal fates. Development 138:4 (2011), 641–652.
51. [51] Sánchez-Alvarez, R., Gayen, S., Vadigepalli, R., Anni, H., Ethanol diverts early neuronal differentiation trajectory of embryonic stem cells by disrupting the balance of lineage specifiers. PLoS One, 8(5), 2013, e63794.
52. [52] Zlotnik, A., Yoshie, O., The chemokine superfamily revisited. Immunity 36:5 (2012), 705–716.
53. [53] Fong, C.Y., Gauthaman, K., Bongso, A., Teratomas from pluripotent stem cells: a clinical hurdle. J. Cell. Biochem. 111:4 (2010), 769–781.
54. [54] Hoffman, B., Liebermann, D.A., Apoptotic signaling by c-MYC. Oncogene 27:50 (2008), 6462–6472.
55. [55] Covello, G., Siva, K., Adami, V., Denti, M.A., An electroporation protocol for efficient DNA transfection in PC12 cells. Cytotechnology 66:4 (2014), 543–553.
56. [56] Abdul Halim, N.S., Fakiruddin, K.S., Ali, S.A., Yahaya, B.H., A comparative study of non-viral gene delivery techniques to human adipose-derived mesenchymal stem cell. Int. J. Mol. Sci. 15:9 (2014), 15044–15060.
57. [57] Yeh, H.Y., Liu, B.H., Hsu, S.H., The calcium-dependent regulation of spheroid formation and cardiomyogenic differentiation for MSCs on chitosan membranes. Biomaterials 33 (2012), 8943–8954.
58. [58] Huang, G.S., Hsieh, P.S., Tseng, C.S., Hsu, S.H., The substrate-dependent regeneration capacity of mesenchymal stem cell spheroids derived on various biomaterial surfaces. Biomater. Sci. 2 (2014), 1652–1660.
59. [59] Guo, J., Wang, Y., Sachs, F., Meng, F., Actin stress in cell reprogramming. Proc. Natl. Acad. Sci. U. S. A. 111:49 (2014), E5252–E5261.